Blasi F - Search Results

1

Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.

Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Sidenius N, et al. Among authors: blasi f. J Neuroimmunol. 2004 Dec;157(1-2):133-9. doi: 10.1016/j.jneuroim.2004.08.038. J Neuroimmunol. 2004. PMID: 15579290

2

Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.

Alfano M, Sidenius N, Panzeri B, Blasi F, Poli G. Alfano M, et al. Among authors: blasi f. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8862-7. doi: 10.1073/pnas.142078099. Proc Natl Acad Sci U S A. 2002. PMID: 12084931 Free PMC article.

3

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F. Sidenius N, et al. Among authors: blasi f. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review.

4

The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection.

Alfano M, Sidenius N, Blasi F, Poli G. Alfano M, et al. Among authors: blasi f. J Leukoc Biol. 2003 Nov;74(5):750-6. doi: 10.1189/jlb.0403176. Epub 2003 Aug 21. J Leukoc Biol. 2003. PMID: 12960238 Review.

5

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.

Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. Cinque P, et al. Among authors: blasi f. Ann Neurol. 2004 May;55(5):687-94. doi: 10.1002/ana.20076. Ann Neurol. 2004. PMID: 15122709

6

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N. Blasi F, et al. FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. FEBS Lett. 2010. PMID: 20036661 Free article. Review.

7

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin.

Sidenius N, Blasi F. Sidenius N, et al. Among authors: blasi f. FEBS Lett. 2000 Mar 17;470(1):40-6. doi: 10.1016/s0014-5793(00)01282-5. FEBS Lett. 2000. PMID: 10722842 Free article.

8

Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo.

Sidenius N, Sier CF, Blasi F. Sidenius N, et al. Among authors: blasi f. FEBS Lett. 2000 Jun 9;475(1):52-6. doi: 10.1016/s0014-5793(00)01624-0. FEBS Lett. 2000. PMID: 10854857 Free article.

9

Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Sidenius N, Andolfo A, Fesce R, Blasi F. Sidenius N, et al. Among authors: blasi f. J Biol Chem. 2002 Aug 2;277(31):27982-90. doi: 10.1074/jbc.M111736200. Epub 2002 May 28. J Biol Chem. 2002. PMID: 12034711 Free article.

10

Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor.

Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Andolfo A, et al. Among authors: blasi f. Thromb Haemost. 2002 Aug;88(2):298-306. Thromb Haemost. 2002. PMID: 12195704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,154 results

Search Page

Filters